Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Conventional chemotherapy is the most common therapeutic method for treating cancer by the application of small toxic molecules thatinteract with DNA and causecell death. Unfortunately, these chemotherapeutic agents are non-selective and can damage both cancer and healthy tissues,producing diverse s...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/4/298 |
id |
doaj-c51994560f7c4b17a9d5a1e1bc089f86 |
---|---|
record_format |
Article |
spelling |
doaj-c51994560f7c4b17a9d5a1e1bc089f862020-11-25T02:04:40ZengMDPI AGPharmaceutics1999-49232020-03-0112429810.3390/pharmaceutics12040298pharmaceutics12040298Polymeric Nanocarriers of Drug Delivery Systems in Cancer TherapyNataša Avramović0Boris Mandić1Ana Savić-Radojević2Tatjana Simić3Institute of Medical Chemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaFaculty of Chemistry, University of Belgrade, Studentski trg 12–16, 11000 Belgrade, SerbiaInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaConventional chemotherapy is the most common therapeutic method for treating cancer by the application of small toxic molecules thatinteract with DNA and causecell death. Unfortunately, these chemotherapeutic agents are non-selective and can damage both cancer and healthy tissues,producing diverse side effects, andthey can have a short circulation half-life and limited targeting. Many synthetic polymers have found application as nanocarriers of intelligent drug delivery systems (DDSs). Their unique physicochemical properties allow them to carry drugs with high efficiency,specificallytarget cancer tissue and control drug release. In recent years, considerable efforts have been made to design smart nanoplatforms, including amphiphilic block copolymers, polymer-drug conjugates and in particular pH- and redox-stimuli-responsive nanoparticles (NPs). This review is focused on a new generation of polymer-based DDSs with specific chemical functionalities that improve their hydrophilicity, drug loading and cellular interactions.Recentlydesigned multifunctional DDSs used in cancer therapy are highlighted in this review.https://www.mdpi.com/1999-4923/12/4/298block copolymerspolymer-drug conjugatespolymeric nanocarrierscancer therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nataša Avramović Boris Mandić Ana Savić-Radojević Tatjana Simić |
spellingShingle |
Nataša Avramović Boris Mandić Ana Savić-Radojević Tatjana Simić Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy Pharmaceutics block copolymers polymer-drug conjugates polymeric nanocarriers cancer therapy |
author_facet |
Nataša Avramović Boris Mandić Ana Savić-Radojević Tatjana Simić |
author_sort |
Nataša Avramović |
title |
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy |
title_short |
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy |
title_full |
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy |
title_fullStr |
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy |
title_full_unstemmed |
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy |
title_sort |
polymeric nanocarriers of drug delivery systems in cancer therapy |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2020-03-01 |
description |
Conventional chemotherapy is the most common therapeutic method for treating cancer by the application of small toxic molecules thatinteract with DNA and causecell death. Unfortunately, these chemotherapeutic agents are non-selective and can damage both cancer and healthy tissues,producing diverse side effects, andthey can have a short circulation half-life and limited targeting. Many synthetic polymers have found application as nanocarriers of intelligent drug delivery systems (DDSs). Their unique physicochemical properties allow them to carry drugs with high efficiency,specificallytarget cancer tissue and control drug release. In recent years, considerable efforts have been made to design smart nanoplatforms, including amphiphilic block copolymers, polymer-drug conjugates and in particular pH- and redox-stimuli-responsive nanoparticles (NPs). This review is focused on a new generation of polymer-based DDSs with specific chemical functionalities that improve their hydrophilicity, drug loading and cellular interactions.Recentlydesigned multifunctional DDSs used in cancer therapy are highlighted in this review. |
topic |
block copolymers polymer-drug conjugates polymeric nanocarriers cancer therapy |
url |
https://www.mdpi.com/1999-4923/12/4/298 |
work_keys_str_mv |
AT natasaavramovic polymericnanocarriersofdrugdeliverysystemsincancertherapy AT borismandic polymericnanocarriersofdrugdeliverysystemsincancertherapy AT anasavicradojevic polymericnanocarriersofdrugdeliverysystemsincancertherapy AT tatjanasimic polymericnanocarriersofdrugdeliverysystemsincancertherapy |
_version_ |
1724941848833687552 |